IN BRIEF: Arecor wins patents in EU, China protecting insulin products

Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Arecor is ...

Alliance News 27 June, 2023 | 10:28AM
Email Form Facebook Twitter LinkedIn RSS

Arecor Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Arecor is awarded key patents in the EU and China protecting the novel formulations of its proprietary Arestat insulin products, AT278 and AT247. The European Patent Office awards patent EP3518892, while China National Intellectual Property Administration grants patent CN110582285. Firm's patent portfolio now comprises 36 patent families, with over 75 granted patents in Europe, the US and other key territories.

"These additional granted patents aim to serve and protect Arecor's innovative technologies in these important markets," says Chief Scientific Officer Jan Jezek.

Current stock price: 230.66 pence, down 3.9% on Tuesday

12-month change: down 34%

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Arecor Therapeutics PLC Ordinary Shares 58.98 GBX 0.81 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures